Drug
Technetium tc-99m tilmanocept clinical trials
Also written Lymphoseek and technetium Tc 99m tilmanocept.
Keep track of what changes. Save the technetium tc-99m tilmanocept studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
21 studies that test it; most in 2017 (4)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 14 · Other 7
Navidea Biopharmaceuticals (11) · Cardinal Health 414, LLC (3) · Kettering Health Network (1) · Duke University (1) · Washington University School of Medicine (1) · John O. Prior (1) · Stanford University (1) · Anna Cruceta (1)
Often tested with
Tested in the same studies.
Technetium Tc 99m Sulfur Colloid (1) · Indocyanine Green (1)
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Studies
Open first, then newest update. How each study uses technetium tc-99m tilmanocept is read from its arms, and is right about nine times in ten.
Testing it · 21
- Repurposing Tilmanocept for Cardiac SarcoidosisRecruitingPhase 2Duke UniversityNCT07159074Written as Tc 99m tilmanocept
- An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)CompletedPhase 1Navidea BiopharmaceuticalsNCT03157167Written as Tc99m-tilmanocept
- Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RATerminatedPhase 3Navidea BiopharmaceuticalsNCT05246280Written as TC99m-tilmanocept
- Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m TilmanoceptCompletedPhase 2Navidea BiopharmaceuticalsNCT04947137Written as Tc99m tilmanocept
- Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RATerminatedPhase 2Navidea BiopharmaceuticalsNCT04078191Written as Tc 99m tilmanocept
- Safety Evaluation of IV Tc 99m Tilmanocept and Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASHTerminatedPhase 1Navidea BiopharmaceuticalsNCT03332940Written as Tc99m-tilmanocept
- A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node MappingCompletedPhase 2Cardinal Health 414, LLCNCT02509598Written as Tc99m tilmanocept
- Mapping Draining Lymph Nodes in CNS MalignanciesTerminatedPhase 1Washington University School of MedicineNCT04096716Written as Tc-99m tilmanocept
- Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic MelanomaTerminatedEarly Phase 1John O. PriorNCT04663126Written as Tc-99m tilmanocept
- Concurrent Use Lymphoseek & Indocyanine Green in Sentinel Lymph Node Detection in Endometrial CancerTerminatedPhase 2Stanford UniversityNCT04511026Written as Lymphoseek
- Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar ImagingCompletedPhase 2Navidea BiopharmaceuticalsNCT03938636Written as Tc 99m tilmanocept
- Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RACompletedPhase 1/2Navidea BiopharmaceuticalsNCT02865434Written as Tc99m-tilmanocept
- Sentinel Lymph Node Biopsy Findings in Patients With Breast CancerCompletedPhase 4Kettering Health NetworkNCT02287675Written as Lymphoseek
- Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast CancerStatus unknownPhase 4Anna CrucetaNCT04261179Written as Lymphoseek
- A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node DissectionTerminatedPhase 2Cardinal Health 414, LLCNCT02509585Written as Tc99m tilmanocept
- Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node BiopsyStatus unknownPhase 4Memorial Health University Medical CenterNCT03199560Written as Tc 99m tilmanocept
- A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the AnusWithdrawnPhase 2Cardinal Health 414, LLCNCT02857608Written as Lymphoseek
- Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CTCompletedPhase 2Navidea BiopharmaceuticalsNCT02201420Written as Tc 99m tilmanocept
- Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell CarcinomaTerminatedPhase 3Navidea BiopharmaceuticalsNCT00911326Written as Lymphoseek
- Breast and Melanoma Trial With Lymphoseek to Identify Lymph NodesCompletedPhase 3Navidea BiopharmaceuticalsNCT01106040Written as Lymphoseek
See all 21 studies that test technetium tc-99m tilmanocept →
Given in every arm · 1 — technetium tc-99m tilmanocept is usual care beside what is tested
Codes
What other systems call technetium tc-99m tilmanocept · ClinicalTrials.gg INT004365
- UNII (FDA) 8IHI69PQTCTECHNETIUM TC-99M TILMANOCEPTOne source FDA
- RxNorm 1373391One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8IHI69PQTC | TECHNETIUM TC-99M TILMANOCEPT | One source FDA |
| RxNorm | 1373391 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.